SHIV neutralization by J3
| SHIV pseudovirus | Clade | IC50 in TZM-bl cells |
| J3 VHH | ||
| µg/ml | ||
| SHIVsf162p4 | B | 0.0685 |
| SHIVsf162p3 | B | 0.2154 |
| SHIV89.6p | B | 0.4215 |
| SHIV89.6 | B | 0.1528 |
| SHIV1157IPD3N4 | C | 0.01976 |
| SHIV1157IP EL-p | C | 0.006205 |
| SHIV pseudovirus | Clade | IC50 in TZM-bl cells |
| J3 VHH | ||
| µg/ml | ||
| SHIVsf162p4 | B | 0.0685 |
| SHIVsf162p3 | B | 0.2154 |
| SHIV89.6p | B | 0.4215 |
| SHIV89.6 | B | 0.1528 |
| SHIV1157IPD3N4 | C | 0.01976 |
| SHIV1157IP EL-p | C | 0.006205 |
VHH J3 neutralization activity was assessed in the indicated SHIV pseudoviruses, as described in Materials and methods. The derivation of SHIV1157IPD3N4 and SHIV1157IP EL-p is described in detail in Humbert et al. (2008). The SHIV neutralization activity of J3 was assayed in duplicate on TZM-bl cells as described in Materials and methods, the subtype B SHIVs assays were undertaken once, and the subtype C SHIVs were assayed in two independent experiments.